Major Depressive Disorder (MDD) is a highly prevalent psychological disorder that affects an estimated 20.6% of adults in the United States. Despite significant research efforts, treatment response rates remain unacceptably low. The Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression (EMBARC) study aimed to address this problem through the search for ;;biosignatures;; that include clinical, contextual, and biological measures to identify a more personalized approach to identifying appropriate treatment recommendations. Through three distinct investigations, this dissertation aims to utilize prior research to study ;;biosignatures;; that may be relevant for predicting antidepressant treatment response. Results from this dissertation may inform future personalized approaches to depression care that may reduce the time to receiving adequate treatment.
【 预 览 】
附件列表
Files
Size
Format
View
Treatment Response in Depression: Predictors and Moderators of Outcome